Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1249631

Impact of vaccination on the presence and severity of symptoms of hospitalised patients with an infection by the omicron variant (B.1.1.529) of the SARS-cov-2 (subvariant BA.1)


Beraud, Guillaume; Bouetard, Laura; Civljak, Rok; Michon, Jocelyn; Tulek, Necla; Lejeune, Sophie; Millot, Romain; Garchet-Beaudron, Aurélie; Lefebvre, Maeva; Velikov, Petar et al.
Impact of vaccination on the presence and severity of symptoms of hospitalised patients with an infection by the omicron variant (B.1.1.529) of the SARS-cov-2 (subvariant BA.1) // Clinical Microbiology and Infection, 28 (2022), 12; CMI 3169, 9 doi:10.1016/j.cmi.2022.12.020 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1249631 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Impact of vaccination on the presence and severity of symptoms of hospitalised patients with an infection by the omicron variant (B.1.1.529) of the SARS-cov-2 (subvariant BA.1)

Autori
Beraud, Guillaume ; Bouetard, Laura ; Civljak, Rok ; Michon, Jocelyn ; Tulek, Necla ; Lejeune, Sophie ; Millot, Romain ; Garchet-Beaudron, Aurélie ; Lefebvre, Maeva ; Velikov, Petar ; Festou, Benjamin ; Abgrall, Sophie ; Lizatovic, Ivan Kresimir ; Baldolli, Aurélie ; Esmer, Huseyin ; Blanchi, Sophie ; Froidevaux, Gabrielle ; Kapincheva, Nikol ; Faucher, Jean-François ; Duvnjak, Mario ; Afşar, Elçin ; Švitek, Luka ; Yarimoglu, Saliha ; Yarimoglu, Rafet ; Janssen, Cécile ; Epaulard, Olivier

Izvornik
Clinical Microbiology and Infection (1198-743X) 28 (2022), 12; CMI 3169, 9

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Breakthrough infection ; Omicron ; SARS-CoV-2 ; Severity ; Vaccine

Sažetak
Objectives: The emergence of SARS-CoV-2 variants raised questions over the extent to which vaccines designed in 2020 have remained effective. We aimed to assess whether vaccine status was associated with the severity of Omicron SARS-CoV-2 infection in hospitalised patients. Methods: We conducted an international, multicentric, retrospective study in 14 centres (Bulgaria, Croatia, France, Turkey). We collected data on patients hospitalised ≥24 hours between 01/12/2021 and 03/03/2022, with PCR-confirmed infection at a time of exclusive Omicron circulation, with hospitalisation related or not to the infection. Patients who had received prophylaxis by monoclonal antibodies were excluded. Patients were considered fully vaccinated if they had received at least 2 injections of either mRNA and/or ChAdOx1-S, or 1 injection of Ad26.CoV2-S vaccines. Results: Among the 1215 patients (median [IQR] age 73.0 [57.0 ; 84.0] ; 51.3% males), 746 (61.4%) were fully vaccinated. In multivariate analysis, being vaccinated was associated with lower 28-day mortality (RR=0.50 [0.32-0.77]), ICU admission (R=0.40 [0.26-0.62], and oxygen requirement (RR=0.34 [0.25-0.46]), independently of age and comorbidities. When co-analysing these Omicron patients with 948 Delta patients from a study we recently conducted, Omicron infection was associated with lower 28-day mortality (RR=0.53 [0.37-0.76]), ICU admission (R=0.19 [0.12-0.28], and oxygen requirements (RR=0.50 [0.38-0.67]), independently of age, comorbidities and vaccination status. Conclusions: Originally designed vaccines have remained effective on severity of Omicron SARS-CoV-2 infection. Omicron is associated with a lower risk of severe forms, independently of vaccination and patient characteristics.

Izvorni jezik
Engleski

Znanstvena područja
Interdisciplinarne prirodne znanosti, Temeljne medicinske znanosti, Javno zdravstvo i zdravstvena zaštita



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Osijek,
Klinika za infektivne bolesti "Dr Fran Mihaljević",
Medicinski fakultet, Osijek

Profili:

Avatar Url Rok Čivljak (autor)

Avatar Url Mario Duvnjak (autor)

Poveznice na cjeloviti tekst rada:

doi www.clinicalmicrobiologyandinfection.com

Citiraj ovu publikaciju:

Beraud, Guillaume; Bouetard, Laura; Civljak, Rok; Michon, Jocelyn; Tulek, Necla; Lejeune, Sophie; Millot, Romain; Garchet-Beaudron, Aurélie; Lefebvre, Maeva; Velikov, Petar et al.
Impact of vaccination on the presence and severity of symptoms of hospitalised patients with an infection by the omicron variant (B.1.1.529) of the SARS-cov-2 (subvariant BA.1) // Clinical Microbiology and Infection, 28 (2022), 12; CMI 3169, 9 doi:10.1016/j.cmi.2022.12.020 (međunarodna recenzija, članak, znanstveni)
Beraud, G., Bouetard, L., Civljak, R., Michon, J., Tulek, N., Lejeune, S., Millot, R., Garchet-Beaudron, A., Lefebvre, M. & Velikov, P. (2022) Impact of vaccination on the presence and severity of symptoms of hospitalised patients with an infection by the omicron variant (B.1.1.529) of the SARS-cov-2 (subvariant BA.1). Clinical Microbiology and Infection, 28 (12), CMI 3169, 9 doi:10.1016/j.cmi.2022.12.020.
@article{article, author = {Beraud, Guillaume and Bouetard, Laura and Civljak, Rok and Michon, Jocelyn and Tulek, Necla and Lejeune, Sophie and Millot, Romain and Garchet-Beaudron, Aur\'{e}lie and Lefebvre, Maeva and Velikov, Petar and Festou, Benjamin and Abgrall, Sophie and Lizatovic, Ivan Kresimir and Baldolli, Aur\'{e}lie and Esmer, Huseyin and Blanchi, Sophie and Froidevaux, Gabrielle and Kapincheva, Nikol and Faucher, Jean-Fran\c{c}ois and Duvnjak, Mario and Af\c{s}ar, El\c{c}in and \v{S}vitek, Luka and Yarimoglu, Saliha and Yarimoglu, Rafet and Janssen, C\'{e}cile and Epaulard, Olivier}, year = {2022}, pages = {9}, DOI = {10.1016/j.cmi.2022.12.020}, chapter = {CMI 3169}, keywords = {Breakthrough infection, Omicron, SARS-CoV-2, Severity, Vaccine}, journal = {Clinical Microbiology and Infection}, doi = {10.1016/j.cmi.2022.12.020}, volume = {28}, number = {12}, issn = {1198-743X}, title = {Impact of vaccination on the presence and severity of symptoms of hospitalised patients with an infection by the omicron variant (B.1.1.529) of the SARS-cov-2 (subvariant BA.1)}, keyword = {Breakthrough infection, Omicron, SARS-CoV-2, Severity, Vaccine}, chapternumber = {CMI 3169} }
@article{article, author = {Beraud, Guillaume and Bouetard, Laura and Civljak, Rok and Michon, Jocelyn and Tulek, Necla and Lejeune, Sophie and Millot, Romain and Garchet-Beaudron, Aur\'{e}lie and Lefebvre, Maeva and Velikov, Petar and Festou, Benjamin and Abgrall, Sophie and Lizatovic, Ivan Kresimir and Baldolli, Aur\'{e}lie and Esmer, Huseyin and Blanchi, Sophie and Froidevaux, Gabrielle and Kapincheva, Nikol and Faucher, Jean-Fran\c{c}ois and Duvnjak, Mario and Af\c{s}ar, El\c{c}in and \v{S}vitek, Luka and Yarimoglu, Saliha and Yarimoglu, Rafet and Janssen, C\'{e}cile and Epaulard, Olivier}, year = {2022}, pages = {9}, DOI = {10.1016/j.cmi.2022.12.020}, chapter = {CMI 3169}, keywords = {Breakthrough infection, Omicron, SARS-CoV-2, Severity, Vaccine}, journal = {Clinical Microbiology and Infection}, doi = {10.1016/j.cmi.2022.12.020}, volume = {28}, number = {12}, issn = {1198-743X}, title = {Impact of vaccination on the presence and severity of symptoms of hospitalised patients with an infection by the omicron variant (B.1.1.529) of the SARS-cov-2 (subvariant BA.1)}, keyword = {Breakthrough infection, Omicron, SARS-CoV-2, Severity, Vaccine}, chapternumber = {CMI 3169} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font